Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03840252
Other study ID # RP 06/15
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 23, 2015
Est. completion date July 31, 2019

Study information

Verified date May 2020
Source IRCCS San Raffaele Roma
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This longitudinal study aims to research cognitive and gait phenotypes of Parkinson's disease and Supranuclear Palsy as well as to provide markers to track diseases progression using a multi-modality approach based on 3D-gait analysis and MR Imaging. Specifically, this study want to identify cognitive pattern and gait-related cerebral diffusion/functional connectivity in PD and PSP patients and to verify their progression over a period of 18 months. In summary, the current protocol proposed to investigate the following issues: - to perform a multifactorial quantitative analysis of outcomes for PD and PSP compared to a control group in order to categorize cognitive and gait pattern in the group of patients and verify if the gait can be useful as discriminator for diagnosis. - to analyze whether diffusion and resting-state functional connectivity indices are correlated with clinical disease severity scores and motor scores and how they change over time (18 months later).


Description:

Gait disorder is one of the key features of Parkinson's disease (PD), often leading to loss of mobility and severe disability. Yet in the early stages of disease, examination of gait may lead to inconclusive results for differential diagnosis between PD and other parkinsonism because slow and small stepped walking is often unspecific and can be related to age, depressive mood, or to a presence of neurodegenerative atypical parkinsonism (AP) such as Progressive Supranuclear Palsy (PSP). At the same time, emerging evidence indicates that early disturbances in cognitive processes such as attention, executive function, and working memory are associated with slower gait and gait instability during single and dual-task testing. It is therefore crucial to carefully investigate the multiple cognitive domains in order to identify possible mild cognitive deficits in PD and PSP patients and to correlate them with gait disorders. The use of quantitative movement analysis with 3D-gait analysis allow an objective multifactorial evaluation of the functional limitation related to PD and PSP patients and can be used to analyze the gait in pathologies characterized by gait impairment compared to healthy control (HC). This longitudinal clinical study aims to analyze cognitive profiles and gait pattern (with 3D-gait analysis) and their progression (18 months later) in a PD- and a PSP-group, respect to HC group. Moreover, with the Magnetic Resonance Imaging (MRI), the study want to research for possible gait-related cerebral diffusion/functional connectivity alterations and their changes over time. The specific aims of the project are: - To perform a multifactorial quantitative analysis of outcomes for PD and PSP compared to a control group in order to categorize the gait in the group of patients and verify if the gait can be useful as discriminator for diagnosis. - To detect possible cognitive deficits in Parkinson's Disease and PSP more corelated with gait disturbances. - To analyze whether diffusion and resting-state functional connectivity indices are correlated with clinical disease severity scores and motor scores and how they change over time (18 months later). - To identify gait-related cerebral diffusion/functional connectivity in PD and PSP patients and to verify their progression over a period of 18 months.


Recruitment information / eligibility

Status Completed
Enrollment 78
Est. completion date July 31, 2019
Est. primary completion date July 25, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria: - Diagnosis of idiopathic PD by United Kingdom (UK) Brain Bank criteria and PSP according to NINDS-SPSP criteria, without other significant neurological or orthopedic problems; - ages of 20-80; - able to walk 25 feet unassisted and without any assistive device Exclusion Criteria: - History of epileptic seizures, head injury, other neurological disorders. - Cardiac pacemaker implantation

Study Design


Intervention

Diagnostic Test:
3D gait analysis
Computed analysis of posture and gait pattern and motor performance by kinematic and kinetics parameters analysis such as the step length, gait velocity, stride time variability, 3D joint kinematics, ground reaction forces, joint kinetics
rsfMRI
MR scans acquired by 1.5 Tesla (Siemens Medical Systems, Erlangen, Germany).
Montreal Cognitive assesment (MoCA)
Standard clinical questionnaire

Locations

Country Name City State
Italy Casa di cura San Raffaele Cassino Cassino Frosinone

Sponsors (1)

Lead Sponsor Collaborator
IRCCS San Raffaele Roma

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Gait profile Score (GPS) in PD and PSP patients GPS quantifies the gait pattern deviation of the patient respect to normality range 18 months
See also
  Status Clinical Trial Phase
Withdrawn NCT05033912 - A Study of CST-2032 in Subjects With Cognitive Impairment Phase 1
Completed NCT02485600 - Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients
Completed NCT03961282 - CODY (Co-design for You): An Immersive Technology Tool for Experiencing and Assessing Home Alterations N/A
Active, not recruiting NCT04041193 - An Innovative Disease-net Management Model for Non-communicable Diseases (SIDERA^B) N/A
Recruiting NCT05395624 - Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers Phase 1/Phase 2